ResearchElevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
ResearchEvolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease Study
ResearchCost-Effectiveness Analysis of Durvalumab in Limited-Stage Small Cell Lung Cancer in the United States
ResearchCharacterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
ResearchInternational Cost-Effectiveness Analysis of Durvalumab in Stage III Non-Small Cell Lung Cancer
ResearchDoes a "Western Lifestyle" Confer a Higher Burden of Colorectal Cancer? A Comparison of EU15+ Countries versus Global Trends between 1990 and 2019
ResearchGenomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors
ResearchHealth Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy
ResearchDisparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma
ResearchEfficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis
ResearchSocial Determinants of Health Impact on Survival of Patients With Malignant Pleural Mesothelioma